Category Archives: Shareholder Letter

CEO: Letter to Shareholders (December)

To our Shareholders, This is an update on actions taken by Ascent Industries Corp. (“Ascent”) since the October 25, 2019 Shareholder Update. CCAA Update Thank you for your continued patience during this CCAA process. Since the last update, the Ascent team has worked to address important new developments in these CCAA proceedings. After considerable consultation [...]

CEO: Letter to Shareholders (October)

Dear Shareholders, I appreciate everyone’s patience in waiting for this update. Further to previous updates, I provide an update on the CCAA process and the timeline to exit this process. Status of Outstanding Claims A question I receive regularly from shareholders is the status of outstanding claims against the Company. The CCAA process includes regular [...]

Statement From CEO Regarding Health Canada Decision

Vancouver, B.C. – Ascent Industries Corp. (CSE: ASNT) ("Ascent" or the “Company”) CEO Paul Dillman released a statement today in response to Health Canada’s July 12, 2019 decision to revoke the Canadian producer and dealer licence (the “Licenses”) of Agrima Botanicals Corp. (“Agrima”), a wholly-owned subsidiary of the Company: "We are disappointed with Health Canada’s [...]